Work

Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.

Year: 2016
Type: article
Abstract: Brexpiprazole (Rexulti): a new monotherapy for schizophrenia and adjunctive therapy for major depressive disorder.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2497303700
FWCI: 0.552
Cites: 7
Cited by: 41
Related to: 10